Autopsy report · NCT06651515

A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia

“Study is being withdrawn for business reasons”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

Seraxis

Sponsor type

Industry

Conditions

Diabetes Mellitus Type 1

Interventions

Allogeneic Pancreatic Endocrine Cell Clusters

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.
  “Study is withdrawn due to company decision.” (89% match in meaning)
• Sym004 Versus TAS-102 in Patients With mCRC
  “Study was withdrawn due to administrative reasons” (87% match in meaning)
• Influence of Pantoprazole on Human Myocardial Contractility at Patients With Congestive Heart Failure
  “Study withdrawn for financial issues” (86% match in meaning)
• Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
  “This study was withdrawn for business reasons.” (85% match in meaning)
• The Influence of Probiotics on Body Weight and Composition
  “study withdrawn due to funding” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.